New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.
Start Your Search

Clinical Trial Offers Hope for HIV Cure

Gammora is a treatment intended to kill HIV-infected cells rather than suppress the spread of the virus.

HIV Invected Cell / Image: Zion Pharma
HIV Invected Cell / Image: Zion Pharma

A recent article from Interesting Engineering discussed Zion Medical, a biotech company out of Israel that focuses on HIV and cancer treatments. Zion just released results of its first clinical trial of Gammora, a new HIV drug that offers hope for a cure to the retrovirus. The treatment consists of a synthetic peptide that integrats with HIV-infected cells and triggers apoptosis, or the cell’s self-destruction.

In a clinical trial, Gammora killed 99% of the HIV virus within just a month of treatment. This method of treatment is preferred over the current options, which just suppress the spread of the virus without offering a cure for the infection. Gammora is safe and “well-tolerable” with no reported side effects. There’s still a lot of work to do before the drug is FDA-approved and available on the market, but these results show promise that we may one day have a cure for HIV.

Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
Test Your Supply Chain Smarts
Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub